Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
72 hedge funds and large institutions have $91.4M invested in Marrone Bio Innovations, Inc. in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 9 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 16
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
3% less funds holding
Funds holding: 74 → 72 (-2)
23% less capital invested
Capital invested by funds: $118M → $91.4M (-$26.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$32.7M |
| 2 |
BlackRock
New York
|
+$2.25M |
| 3 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$1.18M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$501K |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$486K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$405K |
| 2 |
KBC Group
Brussels,
Belgium
|
-$248K |
| 3 |
JP Morgan Chase
New York
|
-$231K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$203K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$184K |
MBII Hedge Fund Activity: Q2 2021 in Review
72 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2021, worth a combined $91.4M — down 23% from $118M a quarter earlier.
Fund positioning in MBII was balanced in Q2 2021: 9 funds opened new positions, 9 closed out, 32 added to existing stakes and 16 trimmed.
The largest buyer was Macquarie Group, opening a new position worth an estimated $32.7M. The largest seller was Millennium Management, cutting an estimated $405K.
- 72 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2021, down from 74 in Q1 2021.
- Funds reported $91.4M of Marrone Bio Innovations, Inc. stock for Q2 2021, down 23% quarter-over-quarter.
- 9 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2021 and 9 closed out, a net change of 0 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q2 2021 was Macquarie Group, an estimated $32.7M added.
- The largest Marrone Bio Innovations, Inc. seller in Q2 2021 was Millennium Management, an estimated $405K sold.
Based on aggregated 13F filings for Q2 2021.